Clinical trial

A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin

NCT07109700

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-04-30

PhasePHASE2

Study timeline

Study start (actual)2025-04-30Date precision: day

Registry last updated2025-08-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

Dulaglutide 1.5 MGDRUG

Sponsors & collaborators

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.lead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07109700 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.